Obermatt
See Similar Stocks →

Faes Farma

MCE:FAE · ES0134950F36
PharmaceuticalsMedium

360

44
Medium confidence — indicative
Profit price43
Cash yield83
Price/Sales72
EV / Gross Profit59
Price/Book77
Returns on capital69
Profit margins61
Cash backing—
Sales growth84
Profit Growth49
Long-Term EPS Growth66
Reinvestment23
Price momentum50
Debt load31
Debt serviceability87
Liquidity66
Analyst ratings3
Opinion Changes50
Price Target Upside6
Market mood47
Value Creation17/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Faes Farma generates returns well above its cost of capital, the foundation of durable shareholder value.

Based on 3/5 components.

Profile

CountrySpain
IndustryPharmaceuticals
SizeMedium
TypePublic Company
ExchangeBME
Founded1933
Employees980
Websitefaesfarma.com
ISINES0134950F36
Last UpdateApr 2, 2026
Index & Theme
Animal FeedLivestockChronic DiseasesNutraceuticalRespiratoryCardiovascularAllergyNeurologyHealth CareManufacturingPharmaceutical

Description

Faes Farma, S.A. (Faes Farma) operates as a pharmaceutical company. The company specializes in the development, manufacture, and distribution of a diverse range of pharmaceuticals, with a focus on prescription drugs, healthcare products, and animal n…

Analysis

Middle-of-the-road

Faes Farma, S.A. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is adequate. The company scores 17/20 on our value-creation score: strong value creator. Analyst sentiment is cautious.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
91
2023202420252026

All-time high

93

Jan 2025

All-time low

66

Jan 2023

Average rank

80

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
72
45
63
77
Price/Earnings
48
72
78
85
Price/Book
77
61
76
71
Dividend Yield
83
91
86
96
Value (overall)
89
86
89
98

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Faes Farma with its peers
Laboratorios Farmaceuticos Rovi
MCE:ROVI
46
CountrySpain
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →
Bayer
GER:BAYN
15
CountryGermany
IndustryPharmaceuticals
SizeXX-Large
Full Stock Analysis →
Perrigo
NYQ:PRGO
8
CountryIreland
IndustryPharmaceuticals
SizeLarge
Full Stock Analysis →
Recordati
MIL:REC
54
CountryItaly
IndustryPharmaceuticals
SizeLarge
Full Stock Analysis →
Teva Pharmaceutical Industries
TLV:TEVA
23
CountryIsrael
IndustryPharmaceuticals
SizeLarge
Full Stock Analysis →
Novartis
VTX:NOVN
38
CountrySwitzerland
IndustryPharmaceuticals
SizeXX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →